Crohn’s disease in a patient with systemic onset juvenile idiopathic arthritis. Association or associated side effect of treatment?

2021 ◽  
Author(s):  
Laura Martín Pedraz ◽  
Rocío Galindo Zavala ◽  
Javier Blasco Alonso ◽  
Víctor Manuel Navas López ◽  
Esmeralda Núñez Cuadros
Keyword(s):  
Juvenile Idiopathic Arthritis ◽  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Side Effect ◽  
Effect Of Treatment ◽  
Systemic Onset

P085 Congestive Heart Failure as a Side Effect of Using Infliximab in the Treatment of Crohn's Disease

2019 ◽  
Vol 114 (1) ◽  
pp. S22-S22 ◽  
Author(s):  
Thais Grillo ◽  
Luciana Almeida ◽  
Diego Queiróz ◽  
Julio Baima ◽  
Rogerio Saad-Hossne ◽  
...  
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Side Effect

scholarly journals Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case

2015 ◽  
Vol 2015 ◽  
pp. 1-2 ◽  
Author(s):  
Michele Sorleto ◽  
Stefanie Dürrwald ◽  
Marcus Wiemer
Keyword(s):  
Inflammatory Bowel Disease ◽  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Drug Treatment ◽  
Bowel Disease ◽  
Side Effect ◽  
Aminosalicylic Acid ◽  
First Line ◽  
Recent Diagnosis ◽  
Inflammatory Bowel

Mesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line. Myocarditis is recognized as a very rare possible side effect of this drug treatment. We present a case of mesalazine-induced myopericarditis that was successfully improved by immediate cessation of the medication.

scholarly journals Azathioprine-Induced Non-Cirrhotic Portal Hypertension in a Patient with Crohn’s Disease

2020 ◽  
Vol 95 (2) ◽  
pp. 119-123
Author(s):  
Min-Kyu Park ◽  
Jae-Kwang Lee ◽  
Hyun-Soo Kim ◽  
Yun-Jin Chung ◽  
Chang-Keun Park ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Crohn’S Disease ◽  
Portal Hypertension ◽  
Crohn's Disease ◽  
Autoimmune Diseases ◽  
Autoimmune Hepatitis ◽  
Organ Transplantation ◽  
Bowel Disease ◽  
Side Effect ◽  
Inflammatory Bowel

Thiopurine-based drugs such as azathioprine and 6-MP are among the most common immunosuppressants used to treat inflammatory bowel disease, autoimmune hepatitis, various autoimmune diseases, and patients undergoing organ transplantation. The drugs are associated with various complications, of which one of the most serious is hepatotoxicity that may trigger non-cirrhotic portal hypertension. We report a case with this side-effect in a patient taking azathioprine to treat Crohn’s disease.

Sign in / Sign up

Export Citation Format

Share Document